Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 4.49540431 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.49540431 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.39135108 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.39135108 |
5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.27049014 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 4.19311145 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.07746738 |
8 | urea cycle (GO:0000050) | 4.06137916 |
9 | urea metabolic process (GO:0019627) | 4.06137916 |
10 | regulation of cholesterol homeostasis (GO:2000188) | 4.05400771 |
11 | kynurenine metabolic process (GO:0070189) | 4.03075632 |
12 | indole-containing compound catabolic process (GO:0042436) | 3.93330182 |
13 | indolalkylamine catabolic process (GO:0046218) | 3.93330182 |
14 | tryptophan catabolic process (GO:0006569) | 3.93330182 |
15 | negative regulation of fibrinolysis (GO:0051918) | 3.89695652 |
16 | * protein carboxylation (GO:0018214) | 3.89305473 |
17 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 3.89305473 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.81339678 |
19 | cysteine metabolic process (GO:0006534) | 3.77769996 |
20 | glyoxylate metabolic process (GO:0046487) | 3.77508770 |
21 | tryptophan metabolic process (GO:0006568) | 3.71434113 |
22 | negative regulation of sterol transport (GO:0032372) | 3.68033761 |
23 | negative regulation of cholesterol transport (GO:0032375) | 3.68033761 |
24 | valine metabolic process (GO:0006573) | 3.67764209 |
25 | nitrogen cycle metabolic process (GO:0071941) | 3.66788874 |
26 | lysine catabolic process (GO:0006554) | 3.65460009 |
27 | lysine metabolic process (GO:0006553) | 3.65460009 |
28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.64757729 |
29 | complement activation, alternative pathway (GO:0006957) | 3.62776581 |
30 | bile acid biosynthetic process (GO:0006699) | 3.59163280 |
31 | sulfur amino acid catabolic process (GO:0000098) | 3.54234481 |
32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.52783291 |
33 | protein localization to endosome (GO:0036010) | 3.51511949 |
34 | mannose metabolic process (GO:0006013) | 3.50880650 |
35 | regulation of fibrinolysis (GO:0051917) | 3.47791827 |
36 | regulation of protein activation cascade (GO:2000257) | 3.43857412 |
37 | homocysteine metabolic process (GO:0050667) | 3.43182502 |
38 | plasma lipoprotein particle clearance (GO:0034381) | 3.38267399 |
39 | plasma lipoprotein particle assembly (GO:0034377) | 3.33707219 |
40 | phospholipid efflux (GO:0033700) | 3.32124382 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 3.30067543 |
42 | response to peptidoglycan (GO:0032494) | 3.28404878 |
43 | amino-acid betaine metabolic process (GO:0006577) | 3.27769442 |
44 | serine family amino acid catabolic process (GO:0009071) | 3.27260502 |
45 | aromatic amino acid family metabolic process (GO:0009072) | 3.25585834 |
46 | detection of other organism (GO:0098543) | 3.24718622 |
47 | 2-oxoglutarate metabolic process (GO:0006103) | 3.23882552 |
48 | regulation of complement activation (GO:0030449) | 3.22984482 |
49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.21035650 |
50 | negative regulation of cell killing (GO:0031342) | 3.21035650 |
51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.18834568 |
52 | detection of bacterium (GO:0016045) | 3.18683335 |
53 | reverse cholesterol transport (GO:0043691) | 3.17963156 |
54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17451033 |
55 | indolalkylamine metabolic process (GO:0006586) | 3.16765912 |
56 | acute-phase response (GO:0006953) | 3.16132987 |
57 | protein-lipid complex assembly (GO:0065005) | 3.15742821 |
58 | tolerance induction (GO:0002507) | 3.15324417 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14593279 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14593279 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.14593279 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14593279 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.14593279 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14593279 |
65 | phospholipid homeostasis (GO:0055091) | 3.13895776 |
66 | cellular extravasation (GO:0045123) | 3.07665902 |
67 | response to muramyl dipeptide (GO:0032495) | 3.05737076 |
68 | low-density lipoprotein particle clearance (GO:0034383) | 3.05470880 |
69 | bile acid metabolic process (GO:0008206) | 3.05173750 |
70 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.04514206 |
71 | triglyceride homeostasis (GO:0070328) | 3.03847660 |
72 | acylglycerol homeostasis (GO:0055090) | 3.03847660 |
73 | fibrinolysis (GO:0042730) | 2.98551636 |
74 | positive regulation of lipid catabolic process (GO:0050996) | 2.96892166 |
75 | protein-lipid complex remodeling (GO:0034368) | 2.96743436 |
76 | macromolecular complex remodeling (GO:0034367) | 2.96743436 |
77 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96743436 |
78 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.95875240 |
79 | response to laminar fluid shear stress (GO:0034616) | 2.94466039 |
80 | regulation of cholesterol esterification (GO:0010872) | 2.93134568 |
81 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.92959085 |
82 | germinal center formation (GO:0002467) | 2.91884901 |
83 | pinocytosis (GO:0006907) | 2.91768337 |
84 | regulation of cholesterol storage (GO:0010885) | 2.91124330 |
85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.89500337 |
86 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.89171403 |
87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88384769 |
88 | detection of external biotic stimulus (GO:0098581) | 2.87858640 |
89 | neutrophil activation involved in immune response (GO:0002283) | 2.87390637 |
90 | alpha-amino acid catabolic process (GO:1901606) | 2.87178709 |
91 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86135754 |
92 | macrophage activation involved in immune response (GO:0002281) | 2.84904808 |
93 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.82599042 |
94 | NIK/NF-kappaB signaling (GO:0038061) | 2.82460370 |
95 | cellular modified amino acid catabolic process (GO:0042219) | 2.80680264 |
96 | cholesterol efflux (GO:0033344) | 2.79890256 |
97 | growth hormone receptor signaling pathway (GO:0060396) | 2.79480687 |
98 | cellular glucuronidation (GO:0052695) | 2.78879707 |
99 | negative regulation of lipid transport (GO:0032369) | 2.77770171 |
100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76999979 |
101 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.75107741 |
102 | 4-hydroxyproline metabolic process (GO:0019471) | 2.73865040 |
103 | plasma lipoprotein particle organization (GO:0071827) | 2.72980159 |
104 | tyrosine metabolic process (GO:0006570) | 2.72564423 |
105 | detection of molecule of bacterial origin (GO:0032490) | 2.70707582 |
106 | benzene-containing compound metabolic process (GO:0042537) | 2.70239772 |
107 | positive regulation of lipid storage (GO:0010884) | 2.69782084 |
108 | glutamate metabolic process (GO:0006536) | 2.69615835 |
109 | glycine metabolic process (GO:0006544) | 2.68918398 |
110 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.66850724 |
111 | protein-lipid complex subunit organization (GO:0071825) | 2.66467092 |
112 | ethanol oxidation (GO:0006069) | 2.66112189 |
113 | response to growth hormone (GO:0060416) | 2.65995324 |
114 | negative regulation of interleukin-12 production (GO:0032695) | 2.64815420 |
115 | cholesterol homeostasis (GO:0042632) | 2.64753115 |
116 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.64359116 |
117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.64359116 |
118 | serine family amino acid metabolic process (GO:0009069) | 2.64340748 |
119 | bile acid and bile salt transport (GO:0015721) | 2.64110928 |
120 | modulation by symbiont of host cellular process (GO:0044068) | 2.63905745 |
121 | sterol homeostasis (GO:0055092) | 2.63723139 |
122 | amine catabolic process (GO:0009310) | 2.62274968 |
123 | cellular biogenic amine catabolic process (GO:0042402) | 2.62274968 |
124 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.61963473 |
125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.61063393 |
126 | cellular amino acid catabolic process (GO:0009063) | 2.60615933 |
127 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.58292477 |
128 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58292477 |
129 | oxaloacetate metabolic process (GO:0006107) | 2.57908310 |
130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57356171 |
131 | tricarboxylic acid metabolic process (GO:0072350) | 2.57126623 |
132 | myeloid dendritic cell differentiation (GO:0043011) | 2.56047017 |
133 | regulation of leukocyte degranulation (GO:0043300) | 2.55995287 |
134 | detection of biotic stimulus (GO:0009595) | 2.50005610 |
135 | barbed-end actin filament capping (GO:0051016) | 2.49403080 |
136 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47368027 |
137 | stress fiber assembly (GO:0043149) | 2.45985660 |
138 | regulation of mast cell degranulation (GO:0043304) | 2.44622048 |
139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39593405 |
140 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39527651 |
141 | regulation of early endosome to late endosome transport (GO:2000641) | 2.39148101 |
142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.38515502 |
143 | leukocyte aggregation (GO:0070486) | 2.37024815 |
144 | positive thymic T cell selection (GO:0045059) | 2.35193343 |
145 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.31941941 |
146 | thymic T cell selection (GO:0045061) | 2.29346627 |
147 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.28885974 |
148 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28746736 |
149 | positive regulation of receptor recycling (GO:0001921) | 2.28640387 |
150 | * positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26525806 |
151 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.26483639 |
152 | modulation by virus of host process (GO:0019054) | 2.25929345 |
153 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.25342986 |
154 | regulation of apoptotic cell clearance (GO:2000425) | 2.25146174 |
155 | regulation of T cell tolerance induction (GO:0002664) | 2.24953640 |
156 | embryonic process involved in female pregnancy (GO:0060136) | 2.24903388 |
157 | hyaluronan catabolic process (GO:0030214) | 2.24564897 |
158 | glycosphingolipid catabolic process (GO:0046479) | 2.24355102 |
159 | basement membrane organization (GO:0071711) | 2.22786716 |
160 | negative regulation of fatty acid transport (GO:2000192) | 2.20919924 |
161 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.19117390 |
162 | immunoglobulin mediated immune response (GO:0016064) | 2.18233240 |
163 | myeloid dendritic cell activation (GO:0001773) | 2.15877683 |
164 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.15139031 |
165 | adhesion of symbiont to host cell (GO:0044650) | 2.14271686 |
166 | virion attachment to host cell (GO:0019062) | 2.14271686 |
167 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.13835348 |
168 | cell-substrate junction assembly (GO:0007044) | 2.13723602 |
169 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.13217304 |
170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.12769077 |
171 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.12290576 |
172 | angiogenesis involved in wound healing (GO:0060055) | 2.12012421 |
173 | adhesion of symbiont to host (GO:0044406) | 2.11909337 |
174 | response to thyroid hormone (GO:0097066) | 2.11290670 |
175 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.11147904 |
176 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.10900032 |
177 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.10870995 |
178 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.09712474 |
179 | response to interleukin-15 (GO:0070672) | 2.09237705 |
180 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.08040402 |
181 | cellular response to type I interferon (GO:0071357) | 2.07935126 |
182 | type I interferon signaling pathway (GO:0060337) | 2.07935126 |
183 | apoptotic cell clearance (GO:0043277) | 2.07855125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.82672276 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04335644 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.53745395 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.06716193 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61956172 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23425456 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.15690811 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.13902050 |
9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00232441 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.74365528 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.69034273 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68432085 |
13 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58750482 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46150027 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43107966 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.31752053 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.26319206 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17693352 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98428324 |
20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90714501 |
21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90558998 |
22 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89964279 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85950743 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.84717828 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84467825 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82770890 |
27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81716954 |
28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72515863 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68116679 |
30 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65733475 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64940840 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.63734575 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62859107 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62106206 |
35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61284664 |
36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60785446 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58931003 |
38 | * MAF_26560356_Chip-Seq_TH1_Human | 1.55803109 |
39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55154261 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53622576 |
41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53186479 |
42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50023800 |
43 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48419420 |
44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46420482 |
45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44463853 |
46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43269776 |
47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41427660 |
48 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39015863 |
49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37891273 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36885244 |
51 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36650813 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36568680 |
53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36063440 |
54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34344836 |
55 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32873928 |
56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31849904 |
57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30208373 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29125482 |
59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27012931 |
60 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25428739 |
61 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.25341449 |
62 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24575127 |
63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23474389 |
64 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22286237 |
65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22258218 |
66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22076656 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21854816 |
68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20979460 |
69 | * MYB_26560356_Chip-Seq_TH1_Human | 1.20054417 |
70 | MYB_26560356_Chip-Seq_TH2_Human | 1.19528205 |
71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17785513 |
72 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16693825 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16458771 |
74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15526186 |
75 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.14792638 |
76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13530657 |
77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13484914 |
78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12787088 |
79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12461560 |
80 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12351579 |
81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10900173 |
82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09147234 |
83 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08752162 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08311886 |
85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07312630 |
86 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07072234 |
87 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06057499 |
88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05732180 |
89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05399085 |
90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04663388 |
91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04490263 |
92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04391046 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04230874 |
94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03961336 |
95 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03163070 |
96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02832104 |
97 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.02832064 |
98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02142169 |
99 | P68_20966046_ChIP-Seq_HELA_Human | 1.00739765 |
100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00640209 |
101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00397305 |
102 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00259789 |
103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00142721 |
104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99647938 |
105 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98011340 |
106 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.97686551 |
107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97198350 |
108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96919271 |
109 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96862847 |
110 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96275119 |
111 | * MAF_26560356_Chip-Seq_TH2_Human | 0.95106334 |
112 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.94851742 |
113 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93771115 |
114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93362878 |
115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93250410 |
116 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92383143 |
117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92360013 |
118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92360013 |
119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91688609 |
120 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.90972694 |
121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88355039 |
122 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87223832 |
123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86696335 |
124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85217700 |
125 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84911746 |
126 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84554160 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.92142630 |
2 | MP0005360_urolithiasis | 4.76122120 |
3 | MP0005365_abnormal_bile_salt | 3.67891724 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.57230180 |
5 | MP0009840_abnormal_foam_cell | 2.98939293 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.95804920 |
7 | MP0003252_abnormal_bile_duct | 2.78539486 |
8 | MP0003300_gastrointestinal_ulcer | 2.69150974 |
9 | MP0003705_abnormal_hypodermis_morpholog | 2.53547196 |
10 | MP0003436_decreased_susceptibility_to | 2.36292153 |
11 | MP0010329_abnormal_lipoprotein_level | 2.27425275 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.20707758 |
13 | MP0005083_abnormal_biliary_tract | 2.20358105 |
14 | MP0003303_peritoneal_inflammation | 2.19774257 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.13511169 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.10217888 |
17 | MP0003172_abnormal_lysosome_physiology | 2.07648703 |
18 | MP0000609_abnormal_liver_physiology | 1.89359870 |
19 | MP0008260_abnormal_autophagy | 1.83696932 |
20 | MP0001666_abnormal_nutrient_absorption | 1.72485535 |
21 | MP0004510_myositis | 1.71612156 |
22 | MP0001790_abnormal_immune_system | 1.70728058 |
23 | MP0005387_immune_system_phenotype | 1.70728058 |
24 | MP0005332_abnormal_amino_acid | 1.69530679 |
25 | MP0003828_pulmonary_edema | 1.64619383 |
26 | MP0003195_calcinosis | 1.61049884 |
27 | MP0003091_abnormal_cell_migration | 1.59401040 |
28 | MP0003724_increased_susceptibility_to | 1.55802118 |
29 | MP0000685_abnormal_immune_system | 1.54468657 |
30 | MP0004019_abnormal_vitamin_homeostasis | 1.49620349 |
31 | MP0005319_abnormal_enzyme/_coenzyme | 1.48947511 |
32 | MP0009785_altered_susceptibility_to | 1.46757234 |
33 | MP0004947_skin_inflammation | 1.45637804 |
34 | MP0002118_abnormal_lipid_homeostasis | 1.41504727 |
35 | MP0003075_altered_response_to | 1.39847294 |
36 | MP0006082_CNS_inflammation | 1.39604185 |
37 | MP0010155_abnormal_intestine_physiology | 1.38480280 |
38 | MP0001958_emphysema | 1.36456157 |
39 | MP0001853_heart_inflammation | 1.34774349 |
40 | MP0008469_abnormal_protein_level | 1.34399679 |
41 | MP0005025_abnormal_response_to | 1.33019742 |
42 | MP0001835_abnormal_antigen_presentation | 1.32784202 |
43 | MP0009764_decreased_sensitivity_to | 1.30132134 |
44 | MP0001800_abnormal_humoral_immune | 1.28698626 |
45 | MP0005409_darkened_coat_color | 1.27724765 |
46 | MP0005464_abnormal_platelet_physiology | 1.27416060 |
47 | MP0003566_abnormal_cell_adhesion | 1.26586728 |
48 | MP0008004_abnormal_stomach_pH | 1.26264710 |
49 | MP0005000_abnormal_immune_tolerance | 1.25114634 |
50 | MP0002419_abnormal_innate_immunity | 1.24882263 |
51 | MP0005451_abnormal_body_composition | 1.21808954 |
52 | MP0001845_abnormal_inflammatory_respons | 1.21312031 |
53 | MP0001851_eye_inflammation | 1.20013499 |
54 | MP0009643_abnormal_urine_homeostasis | 1.18447483 |
55 | MP0001533_abnormal_skeleton_physiology | 1.18089673 |
56 | MP0005076_abnormal_cell_differentiation | 1.17129787 |
57 | MP0000598_abnormal_liver_morphology | 1.16742464 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.15743383 |
59 | MP0010234_abnormal_vibrissa_follicle | 1.14063670 |
60 | MP0002933_joint_inflammation | 1.13715812 |
61 | MP0002405_respiratory_system_inflammati | 1.13684455 |
62 | MP0005671_abnormal_response_to | 1.12250467 |
63 | MP0002723_abnormal_immune_serum | 1.10381142 |
64 | MP0000604_amyloidosis | 1.09513831 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09230718 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.07597236 |
67 | MP0002398_abnormal_bone_marrow | 1.05939034 |
68 | MP0009763_increased_sensitivity_to | 1.05904049 |
69 | MP0005058_abnormal_lysosome_morphology | 1.05816130 |
70 | MP0002254_reproductive_system_inflammat | 1.03985818 |
71 | MP0002452_abnormal_antigen_presenting | 1.03694202 |
72 | MP0008438_abnormal_cutaneous_collagen | 1.03299765 |
73 | MP0005023_abnormal_wound_healing | 1.02327540 |
74 | MP0004272_abnormal_basement_membrane | 1.02280725 |
75 | MP0002796_impaired_skin_barrier | 1.00097235 |
76 | MP0000767_abnormal_smooth_muscle | 0.99814053 |
77 | MP0003045_fibrosis | 0.98311296 |
78 | MP0003329_amyloid_beta_deposits | 0.98108511 |
79 | MP0009278_abnormal_bone_marrow | 0.97505064 |
80 | MP0004858_abnormal_nervous_system | 0.94531100 |
81 | MP0005164_abnormal_response_to | 0.93392281 |
82 | MP0001881_abnormal_mammary_gland | 0.93141055 |
83 | MP0002722_abnormal_immune_system | 0.91450509 |
84 | MP0002429_abnormal_blood_cell | 0.90626854 |
85 | MP0004185_abnormal_adipocyte_glucose | 0.89269681 |
86 | MP0003866_abnormal_defecation | 0.89076154 |
87 | MP0005310_abnormal_salivary_gland | 0.88986584 |
88 | MP0005390_skeleton_phenotype | 0.88939681 |
89 | MP0001873_stomach_inflammation | 0.88502636 |
90 | MP0009333_abnormal_splenocyte_physiolog | 0.87259650 |
91 | MP0002998_abnormal_bone_remodeling | 0.86719879 |
92 | MP0001819_abnormal_immune_cell | 0.86573861 |
93 | MP0002420_abnormal_adaptive_immunity | 0.86243319 |
94 | MP0005670_abnormal_white_adipose | 0.86186306 |
95 | MP0001915_intracranial_hemorrhage | 0.86081747 |
96 | MP0004808_abnormal_hematopoietic_stem | 0.84343771 |
97 | MP0008961_abnormal_basal_metabolism | 0.82550414 |
98 | MP0003868_abnormal_feces_composition | 0.81675729 |
99 | MP0005166_decreased_susceptibility_to | 0.81086772 |
100 | MP0003448_altered_tumor_morphology | 0.80921229 |
101 | MP0005375_adipose_tissue_phenotype | 0.80557547 |
102 | MP0010368_abnormal_lymphatic_system | 0.79951005 |
103 | MP0002166_altered_tumor_susceptibility | 0.79928350 |
104 | MP0002060_abnormal_skin_morphology | 0.79789210 |
105 | MP0002136_abnormal_kidney_physiology | 0.79750341 |
106 | MP0000343_altered_response_to | 0.78762773 |
107 | MP0002148_abnormal_hypersensitivity_rea | 0.77658105 |
108 | MP0001243_abnormal_dermal_layer | 0.77649317 |
109 | MP0003795_abnormal_bone_structure | 0.77312244 |
110 | MP0002168_other_aberrant_phenotype | 0.76756060 |
111 | MP0005397_hematopoietic_system_phenotyp | 0.76333911 |
112 | MP0001545_abnormal_hematopoietic_system | 0.76333911 |
113 | MP0004130_abnormal_muscle_cell | 0.76082025 |
114 | MP0005275_abnormal_skin_tensile | 0.73672246 |
115 | MP0001216_abnormal_epidermal_layer | 0.73552969 |
116 | MP0000249_abnormal_blood_vessel | 0.72609569 |
117 | MP0002877_abnormal_melanocyte_morpholog | 0.72168178 |
118 | MP0003279_aneurysm | 0.71731263 |
119 | MP0004782_abnormal_surfactant_physiolog | 0.71233433 |
120 | MP0009642_abnormal_blood_homeostasis | 0.70576937 |
121 | MP0000858_altered_metastatic_potential | 0.70027950 |
122 | MP0001849_ear_inflammation | 0.69932360 |
123 | MP0003656_abnormal_erythrocyte_physiolo | 0.69353118 |
124 | MP0005666_abnormal_adipose_tissue | 0.69107155 |
125 | MP0000689_abnormal_spleen_morphology | 0.68875021 |
126 | MP0000716_abnormal_immune_system | 0.68703142 |
127 | MP0000465_gastrointestinal_hemorrhage | 0.68284652 |
128 | MP0003763_abnormal_thymus_physiology | 0.67875742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.33883844 |
2 | Xanthomatosis (HP:0000991) | 4.52952932 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.33175673 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29975257 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24752857 |
6 | Myocardial infarction (HP:0001658) | 4.02869886 |
7 | Abnormality of the common coagulation pathway (HP:0010990) | 3.78891978 |
8 | Complement deficiency (HP:0004431) | 3.74304903 |
9 | Joint hemorrhage (HP:0005261) | 3.68146694 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 3.63485725 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54861299 |
12 | Abnormality of macrophages (HP:0004311) | 3.39837617 |
13 | Hypobetalipoproteinemia (HP:0003563) | 3.39181605 |
14 | Hyperlipoproteinemia (HP:0010980) | 3.38946577 |
15 | Esophageal varix (HP:0002040) | 3.17434110 |
16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.10283168 |
17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.08582808 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.08582808 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.08582808 |
20 | Abnormality of complement system (HP:0005339) | 3.03341475 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 2.99088211 |
22 | Eczematoid dermatitis (HP:0000976) | 2.95699562 |
23 | Hypolipoproteinemia (HP:0010981) | 2.93373853 |
24 | Hyperammonemia (HP:0001987) | 2.92643117 |
25 | Epidermoid cyst (HP:0200040) | 2.92565040 |
26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91418465 |
27 | Gingival bleeding (HP:0000225) | 2.83490238 |
28 | Dysostosis multiplex (HP:0000943) | 2.78890576 |
29 | Ketosis (HP:0001946) | 2.77992159 |
30 | Recurrent abscess formation (HP:0002722) | 2.71853976 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71418454 |
32 | Peritonitis (HP:0002586) | 2.68465923 |
33 | Menorrhagia (HP:0000132) | 2.67960347 |
34 | Systemic lupus erythematosus (HP:0002725) | 2.67638133 |
35 | Hypoglycemic coma (HP:0001325) | 2.65072917 |
36 | Recurrent bacterial skin infections (HP:0005406) | 2.60260893 |
37 | Vacuolated lymphocytes (HP:0001922) | 2.59104145 |
38 | Hypercholesterolemia (HP:0003124) | 2.55190771 |
39 | Cerebral aneurysm (HP:0004944) | 2.52090048 |
40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49581539 |
41 | Hyperglycinuria (HP:0003108) | 2.49278157 |
42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47351406 |
43 | Purpura (HP:0000979) | 2.45719354 |
44 | Fat malabsorption (HP:0002630) | 2.43587347 |
45 | Orchitis (HP:0100796) | 2.41988877 |
46 | Protrusio acetabuli (HP:0003179) | 2.41580701 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.41519722 |
48 | Vertebral compression fractures (HP:0002953) | 2.41506274 |
49 | Increased cerebral lipofuscin (HP:0011813) | 2.41008935 |
50 | Mitral stenosis (HP:0001718) | 2.39309560 |
51 | Increased IgE level (HP:0003212) | 2.38687472 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38425456 |
53 | Thrombophlebitis (HP:0004418) | 2.36645912 |
54 | Vascular calcification (HP:0004934) | 2.36172519 |
55 | Myositis (HP:0100614) | 2.36149970 |
56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.36050947 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35709694 |
58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35709694 |
59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35709694 |
60 | Polycythemia (HP:0001901) | 2.35597802 |
61 | Abnormality of proline metabolism (HP:0010907) | 2.35152582 |
62 | Hydroxyprolinuria (HP:0003080) | 2.35152582 |
63 | Premature rupture of membranes (HP:0001788) | 2.33709393 |
64 | Arterial thrombosis (HP:0004420) | 2.33153786 |
65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.32236925 |
66 | Increased mean platelet volume (HP:0011877) | 2.31988857 |
67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31234775 |
68 | Mucopolysacchariduria (HP:0008155) | 2.31234775 |
69 | Hepatocellular carcinoma (HP:0001402) | 2.31208396 |
70 | Prolonged bleeding time (HP:0003010) | 2.28931685 |
71 | Pulmonary embolism (HP:0002204) | 2.28669813 |
72 | Gingivitis (HP:0000230) | 2.27048077 |
73 | Abnormal platelet volume (HP:0011876) | 2.26858414 |
74 | Abnormality of methionine metabolism (HP:0010901) | 2.25965674 |
75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25623761 |
76 | Abnormality of glycine metabolism (HP:0010895) | 2.25623761 |
77 | Cardiovascular calcification (HP:0011915) | 2.24504136 |
78 | Abnormality of iron homeostasis (HP:0011031) | 2.24129352 |
79 | Thin bony cortex (HP:0002753) | 2.23615621 |
80 | Increased density of long bones (HP:0006392) | 2.23379203 |
81 | Increased connective tissue (HP:0009025) | 2.20439871 |
82 | Gastrointestinal infarctions (HP:0005244) | 2.17733572 |
83 | Increased serum ferritin (HP:0003281) | 2.17244384 |
84 | Loss of speech (HP:0002371) | 2.16608958 |
85 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16291384 |
86 | Hyperglycinemia (HP:0002154) | 2.15715992 |
87 | Distal lower limb amyotrophy (HP:0008944) | 2.15465005 |
88 | Skin nodule (HP:0200036) | 2.13181652 |
89 | Gout (HP:0001997) | 2.12370505 |
90 | Abnormal platelet function (HP:0011869) | 2.11073705 |
91 | Impaired platelet aggregation (HP:0003540) | 2.11073705 |
92 | Recurrent fungal infections (HP:0002841) | 2.10146723 |
93 | Hemorrhage of the eye (HP:0011885) | 2.08460088 |
94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07153727 |
95 | Obstructive lung disease (HP:0006536) | 2.07153727 |
96 | Joint swelling (HP:0001386) | 2.06828593 |
97 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06445224 |
98 | Ketoacidosis (HP:0001993) | 2.06188967 |
99 | Epistaxis (HP:0000421) | 2.06103769 |
100 | Distal lower limb muscle weakness (HP:0009053) | 2.03745014 |
101 | Broad face (HP:0000283) | 2.03714477 |
102 | Autoimmune thrombocytopenia (HP:0001973) | 2.03519599 |
103 | Cellulitis (HP:0100658) | 2.03501249 |
104 | Amyloidosis (HP:0011034) | 2.01640979 |
105 | Polygenic inheritance (HP:0010982) | 2.01007155 |
106 | Nephritis (HP:0000123) | 2.00574946 |
107 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99684777 |
108 | Glomerulonephritis (HP:0000099) | 1.99050048 |
109 | Pancreatitis (HP:0001733) | 1.96494904 |
110 | Persistence of primary teeth (HP:0006335) | 1.95741315 |
111 | Optic neuritis (HP:0100653) | 1.95640176 |
112 | Retrobulbar optic neuritis (HP:0100654) | 1.95640176 |
113 | Interstitial pulmonary disease (HP:0006530) | 1.94586027 |
114 | Spondylolisthesis (HP:0003302) | 1.92155837 |
115 | Alopecia of scalp (HP:0002293) | 1.91575683 |
116 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91301523 |
117 | Spontaneous abortion (HP:0005268) | 1.90511244 |
118 | Petechiae (HP:0000967) | 1.89985391 |
119 | Axonal loss (HP:0003447) | 1.89849332 |
120 | Disproportionate tall stature (HP:0001519) | 1.89617984 |
121 | Spastic diplegia (HP:0001264) | 1.88887674 |
122 | Dilatation of the ascending aorta (HP:0005111) | 1.88286104 |
123 | Cervical subluxation (HP:0003308) | 1.87502331 |
124 | Aneurysm (HP:0002617) | 1.87086990 |
125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86699931 |
126 | Hyperbilirubinemia (HP:0002904) | 1.85715398 |
127 | Mediastinal lymphadenopathy (HP:0100721) | 1.85692770 |
128 | Abnormality of the Achilles tendon (HP:0005109) | 1.84078081 |
129 | Anorexia (HP:0002039) | 1.80574031 |
130 | Spontaneous hematomas (HP:0007420) | 1.80386262 |
131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79695104 |
132 | Osteolytic defects of the hand bones (HP:0009699) | 1.79695104 |
133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79407358 |
134 | Bone pain (HP:0002653) | 1.79126403 |
135 | Malnutrition (HP:0004395) | 1.78515582 |
136 | Obstructive sleep apnea (HP:0002870) | 1.78423145 |
137 | Periodontitis (HP:0000704) | 1.78362610 |
138 | Right ventricular cardiomyopathy (HP:0011663) | 1.77934276 |
139 | Pustule (HP:0200039) | 1.77742814 |
140 | Asymmetric septal hypertrophy (HP:0001670) | 1.77620141 |
141 | Meningitis (HP:0001287) | 1.76873807 |
142 | Cholelithiasis (HP:0001081) | 1.76639535 |
143 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76450563 |
144 | Conjugated hyperbilirubinemia (HP:0002908) | 1.76022102 |
145 | Recurrent skin infections (HP:0001581) | 1.75088460 |
146 | Pulmonary infiltrates (HP:0002113) | 1.75058771 |
147 | Keratoconjunctivitis sicca (HP:0001097) | 1.75025170 |
148 | Mitral valve prolapse (HP:0001634) | 1.74559064 |
149 | Pathologic fracture (HP:0002756) | 1.74182092 |
150 | Hypertriglyceridemia (HP:0002155) | 1.73888950 |
151 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73709262 |
152 | Thoracic kyphosis (HP:0002942) | 1.72783390 |
153 | Achilles tendon contracture (HP:0001771) | 1.71415850 |
154 | Neurofibrillary tangles (HP:0002185) | 1.71271132 |
155 | Cerebral inclusion bodies (HP:0100314) | 1.71256759 |
156 | Reticulocytosis (HP:0001923) | 1.71106024 |
157 | Vasculitis (HP:0002633) | 1.70945739 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.02030355 |
2 | PRPF4B | 3.73716815 |
3 | ERN1 | 3.44646534 |
4 | PKN2 | 2.99709065 |
5 | MAP4K1 | 2.95022232 |
6 | FGFR4 | 2.89486205 |
7 | SIK1 | 2.83300679 |
8 | TAOK3 | 2.80003428 |
9 | EPHB1 | 2.42534873 |
10 | IRAK3 | 2.40635084 |
11 | TXK | 2.38329712 |
12 | JAK3 | 2.35891236 |
13 | MAP3K14 | 2.26698045 |
14 | RIPK4 | 2.17628903 |
15 | TBK1 | 2.08962408 |
16 | TYK2 | 2.08587215 |
17 | SMG1 | 2.04025923 |
18 | JAK1 | 1.94352482 |
19 | PTK6 | 1.92885892 |
20 | EPHA3 | 1.92735246 |
21 | BCKDK | 1.88757435 |
22 | TTN | 1.87917962 |
23 | MAP3K13 | 1.77562694 |
24 | EEF2K | 1.74147439 |
25 | ICK | 1.63808853 |
26 | ZAP70 | 1.63718934 |
27 | MAP3K10 | 1.49551984 |
28 | CDK12 | 1.37242250 |
29 | TGFBR2 | 1.36315024 |
30 | MAP2K3 | 1.35163225 |
31 | RIPK1 | 1.32671265 |
32 | STK10 | 1.31767264 |
33 | FES | 1.30849272 |
34 | BMX | 1.27561386 |
35 | JAK2 | 1.27151960 |
36 | KSR2 | 1.24645826 |
37 | MAP3K3 | 1.24574049 |
38 | FGFR3 | 1.23615469 |
39 | CHUK | 1.22387248 |
40 | IKBKE | 1.21901484 |
41 | CDC42BPA | 1.18995379 |
42 | MAP3K7 | 1.18152078 |
43 | CSK | 1.15174644 |
44 | IKBKB | 1.13656243 |
45 | NEK9 | 1.12560357 |
46 | ITK | 1.07006652 |
47 | CDK6 | 1.06772827 |
48 | MAP3K11 | 1.05113538 |
49 | LATS1 | 1.00440222 |
50 | PRKD2 | 0.99790168 |
51 | LRRK2 | 0.97438121 |
52 | MARK2 | 0.95403452 |
53 | PIM1 | 0.92730533 |
54 | ARAF | 0.92417428 |
55 | MST1R | 0.90036285 |
56 | HCK | 0.88579395 |
57 | RPS6KA2 | 0.88566853 |
58 | GRK6 | 0.87116634 |
59 | BLK | 0.86212989 |
60 | RPS6KA4 | 0.84545564 |
61 | CAMK1D | 0.84460288 |
62 | MAP3K6 | 0.81493130 |
63 | FLT3 | 0.81488819 |
64 | BTK | 0.81423223 |
65 | KIT | 0.80834723 |
66 | HIPK2 | 0.78880628 |
67 | SIK3 | 0.78856500 |
68 | FGR | 0.77616140 |
69 | MTOR | 0.75536844 |
70 | TAOK1 | 0.74523348 |
71 | PTK2 | 0.74054902 |
72 | TESK2 | 0.73896592 |
73 | ERBB4 | 0.73787697 |
74 | GSK3A | 0.72112543 |
75 | MOS | 0.71067300 |
76 | RPS6KC1 | 0.70669734 |
77 | RPS6KL1 | 0.70669734 |
78 | MAPK12 | 0.70643831 |
79 | KDR | 0.69888934 |
80 | TNK2 | 0.69810482 |
81 | TRPM7 | 0.69258242 |
82 | PIM2 | 0.69213465 |
83 | PDK1 | 0.69210033 |
84 | EPHA2 | 0.68306128 |
85 | MAPK7 | 0.66901281 |
86 | PRKG2 | 0.66847988 |
87 | NLK | 0.66039425 |
88 | PDGFRA | 0.65590192 |
89 | CDK4 | 0.65009919 |
90 | MAP3K2 | 0.63994720 |
91 | TESK1 | 0.63927515 |
92 | MAPK11 | 0.63548572 |
93 | IRAK2 | 0.63495928 |
94 | SGK3 | 0.62363272 |
95 | LCK | 0.60783777 |
96 | SIK2 | 0.60290610 |
97 | DMPK | 0.60055589 |
98 | DDR2 | 0.59576390 |
99 | TIE1 | 0.58698520 |
100 | STK3 | 0.58497264 |
101 | MAP3K1 | 0.57326583 |
102 | CAMK1G | 0.54898562 |
103 | TEC | 0.54185112 |
104 | PRKAA2 | 0.53727947 |
105 | MATK | 0.52555686 |
106 | PDGFRB | 0.51523658 |
107 | IRAK4 | 0.51134847 |
108 | PAK2 | 0.50726477 |
109 | ALK | 0.50590411 |
110 | PIK3CG | 0.49195179 |
111 | CSF1R | 0.47648491 |
112 | MAP3K5 | 0.47428691 |
113 | IRAK1 | 0.47020516 |
114 | LYN | 0.46738086 |
115 | RET | 0.45396059 |
116 | EGFR | 0.43456981 |
117 | PRKCH | 0.42824454 |
118 | TAOK2 | 0.42058369 |
119 | ABL2 | 0.41763641 |
120 | PAK4 | 0.41270510 |
121 | MARK3 | 0.41093559 |
122 | MAPK4 | 0.39976208 |
123 | DYRK1B | 0.39865257 |
124 | MAPKAPK2 | 0.39077679 |
125 | SYK | 0.39028788 |
126 | MAP3K8 | 0.38796906 |
127 | ABL1 | 0.38727255 |
128 | FGFR1 | 0.38620116 |
129 | PDPK1 | 0.36702448 |
130 | INSRR | 0.36368153 |
131 | RPS6KA6 | 0.35494925 |
132 | NME2 | 0.34305623 |
133 | STK24 | 0.34045477 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44073626 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04932533 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93136418 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70037669 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67039991 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62941411 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44769762 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35806310 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29075532 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21398977 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01311154 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93613252 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93075929 |
14 | Asthma_Homo sapiens_hsa05310 | 1.89545051 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82173603 |
16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.82081959 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79200007 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75274949 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74729580 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67061383 |
21 | Prion diseases_Homo sapiens_hsa05020 | 1.56268746 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.49310314 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47720578 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.47103994 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43051738 |
26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39863934 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39603043 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39540915 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38799034 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36151402 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35679360 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30646644 |
33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30340800 |
34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30264262 |
35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25769262 |
36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25610189 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.25606619 |
38 | Lysine degradation_Homo sapiens_hsa00310 | 1.24652658 |
39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23268163 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21429676 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21111939 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20356670 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19967884 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19472215 |
45 | Bladder cancer_Homo sapiens_hsa05219 | 1.19268817 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18186691 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16587806 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 1.14236594 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11256103 |
50 | * Influenza A_Homo sapiens_hsa05164 | 1.10031120 |
51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08490455 |
52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07121878 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.06834416 |
54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06820719 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.05806794 |
56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05445470 |
57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04552636 |
58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00453025 |
59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99813469 |
60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99279526 |
61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96526962 |
62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95660701 |
63 | Shigellosis_Homo sapiens_hsa05131 | 0.95539286 |
64 | Phagosome_Homo sapiens_hsa04145 | 0.94924009 |
65 | Platelet activation_Homo sapiens_hsa04611 | 0.93929481 |
66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93842132 |
67 | Salmonella infection_Homo sapiens_hsa05132 | 0.93338058 |
68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92414998 |
69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91790314 |
70 | Focal adhesion_Homo sapiens_hsa04510 | 0.90695152 |
71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90418005 |
72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90287322 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90153816 |
74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89807910 |
75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88381776 |
76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86675064 |
77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86574681 |
78 | Measles_Homo sapiens_hsa05162 | 0.84759390 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.84642109 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84406317 |
81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82742577 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81085909 |
83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78246031 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76840413 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76721224 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76699152 |
87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76295890 |
88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75401919 |
89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75065000 |
90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72547569 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71909287 |
92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71870756 |
93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71470509 |
94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71443213 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71037906 |
96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70613550 |
97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70431154 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70071916 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69661287 |
100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69627393 |
101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69476614 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.67973154 |
103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67371266 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67016813 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65675242 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64868726 |
107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62695545 |
108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62216690 |
109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61993178 |
110 | Prostate cancer_Homo sapiens_hsa05215 | 0.61874650 |
111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61756701 |
112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61737534 |
113 | Glioma_Homo sapiens_hsa05214 | 0.61474099 |
114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60669360 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60549991 |
116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59715458 |
117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57260398 |
118 | Malaria_Homo sapiens_hsa05144 | 0.57156314 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57063607 |
120 | Legionellosis_Homo sapiens_hsa05134 | 0.56913026 |
121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56458168 |
122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55325183 |
123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55114886 |
124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54716546 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54619986 |
126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53219795 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52318505 |
128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52283146 |
129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51907653 |
130 | Amoebiasis_Homo sapiens_hsa05146 | 0.51772476 |
131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50918550 |
132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50527049 |
133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50031814 |
134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48906601 |
135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48766293 |
136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48165424 |
137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47917014 |
138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47701679 |
139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47281863 |
140 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46658138 |
141 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45777938 |
142 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45647486 |
143 | Pertussis_Homo sapiens_hsa05133 | 0.44668721 |
144 | Apoptosis_Homo sapiens_hsa04210 | 0.44194295 |
145 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43661912 |
146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43332634 |
147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41545434 |
148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40386613 |
149 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40055797 |
150 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39818609 |
151 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39474494 |
152 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39460325 |
153 | Hepatitis C_Homo sapiens_hsa05160 | 0.38725557 |
154 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38555439 |
155 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38450947 |
156 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38045314 |
157 | Tuberculosis_Homo sapiens_hsa05152 | 0.36387578 |
158 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35976211 |
159 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35595658 |